Science
Mechanism of Action
Functions as a competitive ligand that binds to galectins (particularly Galectin-1 and -7) to regulate cellular proliferation and migration, while simultaneously outcompeting pathogenic S. aureus bacteria for corneocyte binding sites, thereby reducing harmful colonization and inflammation
Research
Clinical Evidence
Medium confidence1%
Key findings
- 01 Demonstrates competitive inhibition of pathogenic bacterial adhesion when used synergistically with other N-acetylated sugars at 0.1-2% concentrations
- 02 Shows high-affinity binding to galectins that control keratinocyte behavior and wound repair mechanisms
Transparency
Dusting Analysis
As a specialized microbiome-modulating ingredient, concentrations below 0.05% are unlikely to provide meaningful competitive inhibition of bacterial adhesion
The Formula
Formulation
Stability
Highly hygroscopic with excellent thermal stability in aqueous solutions; vulnerable to glycosidic bond hydrolysis below pH 3
Synergies
- N-acetylglucosamine
- hyaluronic acid
- ceramides
Conflicts
- strong oxidizing agents
- highly acidic ingredients
Safety
Safety Profile
Component monomers (galactose and N-acetylglucosamine) have established safety profiles; FDA registered under UNII: 3Y5B2K5OOK
Your Skin
Skin Compatibility
Our Assessment
Verdict
A scientifically sophisticated ingredient that addresses both microbiome balance and barrier function, though requires proper concentration for efficacy.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources